Study Preview
Study Title and Description
Cadaveric fascia lata versus intravaginal slingplasty for the pubovaginal sling: surgical outcome, overall success and patient satisfaction rates
Key Questions Addressed
1 | Sling vs Comparator RCT outcomes (excluding AEs) | |
2 | Sling Adverse Events |
Primary Publication Information
Title | Cadaveric fascia lata versus intravaginal slingplasty for the pubovaginal sling: surgical outcome, overall success and patient satisfaction rates |
Author | Basok EK, Yildirim A, Atsu N, Basaran A, Tokuc R |
Country | -- |
Year | 2008 |
Numbers |
Pubmed ID: 18204233 3005 (internal) |
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Sling vs Comparator RCT outcomes (excluding AEs)
Arms
Number | Title | Description | Comments |
---|---|---|---|
1 | PVS, fascial | Cadaveric fascia lata | |
2 | IVS |
Question... Follow Up | Answer | Follow-up Answer | |
---|---|---|---|
Country ... | Other ... | Turkey | |
Outcome Categories Reported | Subjective SUI | ||
OR outcomes/complications (not "AEs") | |||
Population (reason for surgery etc.) | Symptomatic SUI | ||
Mixed incontinence | |||
RCT Comparison Category | Pubovaginal sling vs. Other | ||
Multicenter | No | ||
Institution Type | Academic hospital | ||
Number of surgeons performing procedures | Not reported | ||
Surgeons' Training | Urology | ||
Residents or fellows performing surgery? | Unclear/Not reported | ||
Study Quality (overall) | C (poor) | ||
Study Sponsor/Funding | Industry |
Baseline Characteristics
Question | PVS, fascial | IVS | Fascial PVS | IVS | Total | Comments | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Answer | Follow-up | Answer | Follow-up | Answer | Follow-up | Answer | Follow-up | Answer | Follow-up | ||
No. Randomized | 67 | 72 | |||||||||
Mean Age | 47.4 | 50.3 | |||||||||
Post-Op Follow-Up Interval (Maximum) | 12 mo | 12 mo |
Results & Comparisons
Results Data
Outcome: "Cure" Population: All Participants | |||||
---|---|---|---|---|---|
Time Point | Measure | PVS, fascial | IVS | Fascial PVS | IVS |
12 months |
Percentage | 52.2 | 47.2 |
Outcome: "Improvement" Population: All Participants | |||||
---|---|---|---|---|---|
Time Point | Measure | PVS, fascial | IVS | Fascial PVS | IVS |
12 months |
Percentage | 26.8 | 23.6 |
Outcome: "Total Success Rate" Population: All Participants | |||||
---|---|---|---|---|---|
Time Point | Measure | PVS, fascial | IVS | Fascial PVS | IVS |
12 months |
Percentage | 79.0 | 70.8 |
Outcome: Satisfaction Population: All Participants | |||||
---|---|---|---|---|---|
Time Point | Measure | PVS, fascial | IVS | Fascial PVS | IVS |
12 months |
Percentage | 82.0 | 87.5 |
Outcome: OR time Population: All Participants | |||||
---|---|---|---|---|---|
Time Point | Measure | PVS, fascial | IVS | Fascial PVS | IVS |
0 N/A |
N Analyzed | 67 | 72 | ||
Mean | 50 | 25 |
Extraction Form: Sling Adverse Events
Arms
Number | Title | Description | Comments |
---|---|---|---|
1 | Fascial PVS | Cadaveric fascia lata | |
2 | IVS |
Question... Follow Up | Answer | Follow-up Answer | |
---|---|---|---|
Study Type | RCT | ||
Sling Category | Pubovaginal (bladder neck) | ||
Adverse Event Ascertainment | Unclear/Not reported | ||
Was the Clavien-Dindo Classification of Surgical Complications system used? | No / Not reported | ||
Was a data safety monitoring board used? | No / Not reported |
Results & Comparisons
Results Data
Outcome: "Cure" Population: All Participants | |||||
---|---|---|---|---|---|
Time Point | Measure | PVS, fascial | IVS | Fascial PVS | IVS |
12 months |
Percentage | 52.2 | 47.2 |
Outcome: "Improvement" Population: All Participants | |||||
---|---|---|---|---|---|
Time Point | Measure | PVS, fascial | IVS | Fascial PVS | IVS |
12 months |
Percentage | 26.8 | 23.6 |
Outcome: "Total Success Rate" Population: All Participants | |||||
---|---|---|---|---|---|
Time Point | Measure | PVS, fascial | IVS | Fascial PVS | IVS |
12 months |
Percentage | 79.0 | 70.8 |
Outcome: Satisfaction Population: All Participants | |||||
---|---|---|---|---|---|
Time Point | Measure | PVS, fascial | IVS | Fascial PVS | IVS |
12 months |
Percentage | 82.0 | 87.5 |
Outcome: OR time Population: All Participants | |||||
---|---|---|---|---|---|
Time Point | Measure | PVS, fascial | IVS | Fascial PVS | IVS |
0 N/A |
N Analyzed | 67 | 72 | ||
Mean | 50 | 25 |
Adverse Events
Arm or Total | Title | Description | Follow-up time | In-hospital or After discharge | Is event serious? | Reported definition of serious event | Number affected | Number at risk (analyzed) | Difference between 2 slings (eg, OR/RR or %, with 95% CI) | Reported P value between slings | Comments |
---|---|---|---|---|---|---|---|---|---|---|---|
Fascial PVS | Organ injury in OR (urethra, bladder, bowel) | Bladder perforation | Intraop | In-hospital | ND | ND | 3 | 67 | ND | 0.147 | |
IVS | Intraop | In-hospital | ND | ND | 8 | 72 | |||||
Total | |||||||||||
Fascial PVS | Hematoma | "Late" | After discharge | ND | ND | 0 | 67 | ND | NS | ||
IVS | "Late" | After discharge | ND | ND | 0 | 72 | |||||
Total | |||||||||||
Fascial PVS | Defective vaginal healing | "Late" | After discharge | ND | ND | 0 | 67 | ND | NS | ||
IVS | "Late" | After discharge | ND | ND | 0 | 72 | |||||
Total | |||||||||||
Fascial PVS | Mesh erosion/extrusion/exposure/granulation tissue | "Late" | After discharge | ND | ND | 0 | 67 | ND | NS | ||
IVS | "Late" | After discharge | ND | ND | 0 | 72 | |||||
Total | |||||||||||
Fascial PVS | Urinary retention | Catheterization up to a month | >1mo | After discharge | ND | ND | 8 | 67 | ND | 0.878 | |
IVS | >1mo | After discharge | ND | ND | 8 | 72 | |||||
Total | |||||||||||
Fascial PVS | Retention requiring surgery | Release of fascial sling sutures | >1mo | After discharge | Yes | ND | 2 | 67 | ND | 1.0 | |
IVS | >1mo | After discharge | Yes | ND | 0 | 72 | |||||
Total | |||||||||||
Fascial PVS | De novo UUI | ND | After discharge | ND | ND | 15 | 67 | ND | 0.009 | ||
IVS | ND | After discharge | ND | ND | 5 | 72 | |||||
Total | |||||||||||
Fascial PVS | Persistent UUI | ND | After discharge | ND | ND | 37 | 67 | ND | 0.0001 | ||
IVS | ND | After discharge | ND | ND | 18 | 72 | |||||
Total |